Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
RESEARCH TOOLSreports
Mineralys Therapeutics, Inc. (MLYS) Ownership - Who Owns Mineralys Therapeutics, Inc.?
258 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 14, 2024 | Samsara Biocapital Gp, Llc >10% Owner | Bought | $7499993 |
| Nov 27, 2023 | Jon Congleton Ceo,director | Bought | $25330 |
| Sep 08, 2023 | Jon Congleton Ceo,director | Bought | $27180 |
| Aug 21, 2023 | Jon Congleton Ceo,director | Bought | $27225 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Sold | $59799 | |
| Mar 31, 2024 | Sold | $2366364 | |
| Mar 31, 2024 | Bought | $62626203 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,850,984 | Institution | 9.77% | 58,939,456 | |
| 1,220,828 | Institution | 2.46% | 14,833,060 | |
| 952,000 | Institution | 1.92% | 11,566,800 | |
| 852,912 | Institution | 1.72% | 10,362,881 | |
| 622,059 | Institution | 1.25% | 7,558,017 | |
| 435,885 | Institution | 0.88% | 5,296,003 | |
| 280,824 | Institution | 0.57% | 3,412,012 | |
| 242,942 | Institution | 0.49% | 2,951,745 | |
| 208,557 | Institution | 0.42% | 2,533,968 | |
| 206,422 | Institution | 0.42% | 2,508,027 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 852,912 | Institution | 1.72% | 10,362,881 | |
| 622,059 | Institution | 1.25% | 7,558,017 | |
| 435,885 | Institution | 0.88% | 5,296,003 | |
| 280,824 | Institution | 0.57% | 3,412,012 | |
| 242,942 | Institution | 0.49% | 2,951,745 | |
| 208,557 | Institution | 0.42% | 2,533,968 | |
| 206,422 | Institution | 0.42% | 2,508,027 | |
| 163,942 | Institution | 0.33% | 1,991,895 | |
| 86,490 | Institution | 0.17% | 1,050,854 | |
| 55,096 | Institution | 0.11% | 669,416 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 669,649 | Institution | 1.35% | 8,551,418 | |
| 681,077 | Institution | 1.37% | 8,275,086 | |
| 208,970 | Institution | 0.42% | 2,538,986 | |
| 193,358 | Institution | 0.39% | 2,469,182 | |
| 149,726 | Institution | 0.30% | 1,819,171 | |
| 105,446 | Institution | 0.21% | 1,274,842 | |
| 73,094 | Institution | 0.15% | 933,410 | |
| 72,813 | Institution | 0.15% | 886,134 | |
| 62,459 | Institution | 0.13% | 758,877 | |
| 55,790 | Institution | 0.11% | 677,849 |
FAQ
Who Owns Mineralys Therapeutics, Inc. (MLYS)?
Currently, no data Available
What percentage of Mineralys Therapeutics, Inc. (MLYS) stock is held by institutional investors?
Currently, no data Available
What percentage of Mineralys Therapeutics, Inc. (MLYS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Mineralys Therapeutics, Inc. (MLYS)?
Peter Kolchinsky owns the most shares of Mineralys Therapeutics, Inc. (MLYS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.